Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-01 Sale |
2024-08-05 4:49 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
65,693,524 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-10-16 Purchase |
2023-10-18 4:30 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
5,480,052 | $22.81 | $124,999,986 | 65,683,063 (Indirect Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 8:38 pm |
SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
1,000,000 | $70.25 | $70,250,000 | 4,832,413 (Indirect Direct) |
View |
| 2021-07-19 Purchase |
2021-07-21 4:40 pm |
RAPID MICRO BIOSYSTEMS INC. | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
100,000 | $20 | $2,000,000 | 8,434,560 (Indirect) |
View |
| 2021-03-09 Sale |
2021-03-11 4:30 pm |
SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
1,450,000 | $71.5 | $103,675,000 | 5,831,307 (Indirect) |
View |
| 2020-12-10 Sale |
2020-12-14 5:35 pm |
Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director |
1,000,000 | $23.4 | $23,400,000 | 3,080,237 (Indirect) |
View |
| 2020-11-09 Purchase |
2020-11-12 5:54 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
332,293 | $10.3 | $3,422,618 | 60,632,356 (Indirect) |
View |
| 2020-10-27 Purchase |
2020-10-29 8:00 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
10,000,000 | $10 | $100,000,000 | 110,262,006 (Indirect) |
View |
| 2020-10-26 Purchase |
2020-10-27 5:07 pm |
Aptinyx Inc. | APTX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
3,333,333 | $3 | $9,999,999 | 8,891,758 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 4:45 pm |
Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Bain Capital Life Sciences Partners LP Schwartz Jeffrey Lawrence 10% Owner |
400,000 | $17 | $6,800,000 | 3,241,628 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-28 4:00 pm |
2025-06-26 2034-06-25 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
16,000 | $5.52 | 16,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:12 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
10,461 | $0 | 65,693,524 (Direct) |
View |
| 2024-01-11 Option Award |
2024-01-12 4:56 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner |
904,160 | $5.53 | 4,034,582 (Indirect) |
View |
| 2023-06-21 Option Award |
2023-06-22 8:12 pm |
2024-06-21 2033-06-20 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-07 Other |
2023-06-09 5:07 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
432,627 | $0 | 60,649,418 (Indirect) |
View |
| 2023-06-07 Option Award |
2023-06-09 5:07 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
17,062 | $0 | 60,649,418 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 5:01 pm |
N/A 2033-06-06 |
Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner |
9,650 | $0 | 9,650 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:19 pm |
N/A 2032-12-13 |
Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner |
9,650 | $0 | 9,650 (Direct) |
View |
| 2022-12-02 Option Award |
2022-12-05 5:16 pm |
N/A 2032-12-01 |
Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner |
2,666 | $0 | 2,666 (Direct) |
View |
Ownership |
2022-12-05 4:58 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Koppel Adam Director 10% Owner |
0 | $0 | 3,130,423 (Indirect) |
View |
| 2022-06-21 Option Award |
2022-06-22 8:59 pm |
2023-06-21 2032-06-20 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 5:10 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 5:06 pm |
N/A 2032-05-25 |
Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-12-28 Equity Swap |
2021-12-29 4:43 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director |
3,083,570 | $38.25 | 0 (Direct) |
View |
| 2021-07-19 Conversion |
2021-07-21 4:40 pm |
N/A N/A |
RAPID MICRO BIOSYSTEMS INC. | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
50,007,380 | $0 | 8,434,560 (Indirect) |
View |
Ownership |
2021-07-14 8:02 pm |
N/A N/A |
RAPID MICRO BIOSYSTEMS INC. | RPID | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
0 | $0 | 8,334,560 (Indirect) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:53 pm |
2022-07-13 2031-07-12 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
12,530 | $0 | 12,530 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 5:15 pm |
N/A 2031-06-16 |
Solid Biosciences Inc. | SLDB | Koppel Adam Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:25 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
42,950 | $0 | 42,950 (Direct) |
View |
| 2021-06-03 Exercise |
2021-06-07 6:50 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director |
3,333 | $0 | 3,101,903 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 6:50 pm |
N/A N/A |
Dicerna Pharmaceuticals Inc | DRNA | Koppel Adam Director |
18,333 | $0 | 3,101,903 (Direct) |
View |
| 2021-05-27 Option Award |
2021-06-01 4:30 pm |
N/A 2031-05-26 |
Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-03-23 Option Award |
2021-03-25 4:30 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Koppel Adam Director |
869,565 | $5.75 | 7,929,918 (Indirect) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:44 pm |
N/A 2030-12-30 |
Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner |
5,508 | $2.224 | 5,508 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-11 4:30 pm |
N/A N/A |
Solid Biosciences Inc. | SLDB | Koppel Adam Director |
3,189,189 | $3.7 | 7,060,353 (Indirect) |
View |
| 2020-10-27 Other |
2020-10-29 8:00 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
49,961,943 | $0 | 110,262,006 (Indirect) |
View |
Ownership |
2020-10-29 7:45 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director |
0 | $0 | 338,120 (Indirect) |
View |
| 2020-10-26 Option Award |
2020-10-26 4:30 pm |
N/A N/A |
BCLS Acquisition Corp. | BLSA | Koppel Adam Director 10% Owner |
487,500 | $10 | 487,500 (Indirect) |
View |
Ownership |
2020-10-22 9:03 pm |
N/A 2028-01-30 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-21 8:05 pm |
N/A N/A |
BCLS Acquisition Corp. | BLSA | Koppel Adam Director 10% Owner |
0 | $0 | 3,503,750 (Indirect) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:15 pm |
N/A 2030-09-29 |
Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner |
5,663 | $2.163 | 5,663 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 4:45 pm |
N/A N/A |
Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Bain Capital Life Sciences Partners LP Schwartz Jeffrey Lawrence 10% Owner |
27,876,392 | $0 | 3,241,628 (Indirect) |
View |
Ownership |
2020-07-23 5:06 pm |
N/A N/A |
Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Koppel Adam Schwartz Jeffrey Lawrence 10% Owner |
0 | $0 | 25,034,764 (Indirect) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:06 pm |
N/A 2030-06-29 |
Aptinyx Inc. | APTX | Koppel Adam Director 10% Owner |
4,370 | $2.677 | 4,370 (Direct) |
View |